Objective: Help BioPharma & Innovative Businesses grow in the next phase of their journey and effectively partner in life sciences and healthcare
INDUSTRIES / DOMAIN
Biotechnology
Precision Medicine
Pharmaceuticals
Healthcare Technology / AI
BACKGROUND / IMPACT
-
Sangeetha began her career as an Oncology scientist, helping innovative firms and ideas gain commercial success
-
Integrated Digital AI for growth & resource optimization
-
Gained years of experience in driving commercial and operational execution preparedness within companies
-
"Adoption-readiness" is a differentiator
CORE VALUES OFFERED
THE CHALLENGE
Clinical and R&D productivity remains a grand challenge impacting both big pharma and hospitals - the roughly 1/3rd reduction in Pharma ROI will have to be offset
Biotech and Healthtech organizations are likely to hit roadblocks in prioritizing their approach and identifying their most viable value proposition and customer
THE SOLUTION
The winners are likely the ones who understand current pain points, how to articulate their value and when to approach the right partner
Growth for large industry organizations will rely on leaning into digital dexterity, effectively integrating healthcare technology and driving the right external alliances and partnerships
Sangeetha Ramsagar
MBA, Entrepreneurship and Innovation, Stern School of Business, NYU
MS, Cellular and Molecular Genetics, The Ohio State University
At Kronos, Sangeetha helps analyze assets, prioritize focus areas, identify the best approach, make meaningful partnership connections and provide sustainable solutions for business growth. The desired outcome is to help free up your time to focus on your asset while transforming clinical and commercial strategy
If you are a growing organization, prioritizing which functional groups to approach, then developing the right road map is going to be critical in establishing successful partnerships & approvals
Organizations that stay afloat will be the ones with a sustainable plan
Sources: Morgan Stanley Bio NJ 2023, Capital IQ, S&P Biotech Select Industry Index
Partnership & Support Brief
-
Commercial & Clinical Development Strategy (Oncology, Healthcare Tech & AI solutions)
-
Investor & BD pitch presentations
-
C-Suite & decision-maker approach
-
Commercial operations Integration plans
-
Market differentiation, impact value analysis and approach
-
-
Companion diagnostics & precision medicine strategy
-
Key Business Questions for Drug development early Discovery
-
3-5 year CDx Launch-plan
-
-
Portfolio and lifecycle management
-
Drug development and clinical strategy with a commercial lens
-
-
Acquisition leads
-
Seed funding support
-
Partnership & deal structures with a commercial and operations lens to maximize adoption
Work Experience Brief
2016-2023
Director, Strategic Business Transformation
2017-2019
Executive in Residence: Guest lecturer, Business & Economics of Healthcare, Healthcare Conference Advisor and Panelist Precision Medicine Oncology
2019-2023
Developed ready for proof-of-concept game theory asset for pediatric compliance in Diabetes & Obesity
2013-2016
Global Lead, Precision Medicine Commercial Strategy and Early Pipeline Portfolio Management
2011-2023
Companion Diagnostics Portfolio Leader and Lung Cancer Pipeline Launch Lead
2001-2011
-
Global Strategic Business Development
-
Inline Marketing Patient Segment Leader